---
figid: PMC2861953__fig-2
figlink: /pmc/articles/PMC2861953/figure/f2/
number: F2
caption: Altered signaling pathways and mouse models of thyroid cancer. Mouse models
  are indicated by an (*). Aberrant signaling through receptor tyrosine kinases (RTK)
  such as the RET and NTRK1 receptors induce papillary thyroid cancer (PTC). Overactivation
  of the RAS/RAF/MEK/ERK pathway (or MAPK signaling pathway) leads to PTC. The BRAFV600E
  mutation results in constitutive activation of BRAF and is commonly found in PTC.
  RAS overactivation is common to both papillary and follicular thyroid cancer (FTC)
  models. TSH receptor (TSHR) signaling via adenyl cyclases/cAMP/protein kinase A
  (PKA) is important for normal thyroid growth, but only a few models of TSHR overactivation
  develop thyroid cancer (Prkar1aΔ2/+, Rap1bG12V). The adrenergic receptor may also
  contribute to thyroid cancer development also through increased cAMP and signaling
  via pathways such as MAPK and protein kinase C (PKC). Overactivation in the PI3K-AKT
  signaling pathway via cell-surface receptors such TSHR or inactivation of the phosphatase,
  PTEN, are important for FTC tumorigenesis. TRßPV/PV mice also have PI3K-AKT overactivation
  and develop FTC. Please see text for additional details regarding these mouse models.
pmcid: PMC2861953
papertitle: Lessons from Mouse Models of Thyroid Cancer.
reftext: Caroline S. Kim, et al. Thyroid. 2009 Dec;19(12):1317-1331.
pmc_ranked_result_index: '5944'
pathway_score: 0.9572192
filename: fig-2.jpg
figtitle: Altered signaling pathways and mouse models of thyroid cancer
year: '2009'
organisms:
- Homo sapiens
ndex: a0298480-dedf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2861953__fig-2.html
  '@type': Dataset
  description: Altered signaling pathways and mouse models of thyroid cancer. Mouse
    models are indicated by an (*). Aberrant signaling through receptor tyrosine kinases
    (RTK) such as the RET and NTRK1 receptors induce papillary thyroid cancer (PTC).
    Overactivation of the RAS/RAF/MEK/ERK pathway (or MAPK signaling pathway) leads
    to PTC. The BRAFV600E mutation results in constitutive activation of BRAF and
    is commonly found in PTC. RAS overactivation is common to both papillary and follicular
    thyroid cancer (FTC) models. TSH receptor (TSHR) signaling via adenyl cyclases/cAMP/protein
    kinase A (PKA) is important for normal thyroid growth, but only a few models of
    TSHR overactivation develop thyroid cancer (Prkar1aΔ2/+, Rap1bG12V). The adrenergic
    receptor may also contribute to thyroid cancer development also through increased
    cAMP and signaling via pathways such as MAPK and protein kinase C (PKC). Overactivation
    in the PI3K-AKT signaling pathway via cell-surface receptors such TSHR or inactivation
    of the phosphatase, PTEN, are important for FTC tumorigenesis. TRßPV/PV mice also
    have PI3K-AKT overactivation and develop FTC. Please see text for additional details
    regarding these mouse models.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - PRKAR2B
  - PRKACG
  - PRKACB
  - MAP2K1
  - MAP2K2
  - PRKACA
  - RET
  - TSHR
  - AKT1
  - NTRK1
  - MAPK1
  - PRKD3
  - MAPK13
  - PRKAR2A
  - PIK3CG
  - PRKCD
  - PIK3CB
  - AKT2
  - PRKAR1B
  - PIK3R4
  - PIK3R3
  - MAPK12
  - PRKCB
  - GPR162
  - NCOA4
  - MAPK10
  - AKT3
  - PRKAR1A
  - PRKCA
  - PRKCE
  - PIK3R6
  - PRKCZ
  - PRKCI
  - PIK3CA
  - PIK3CD
  - PRKCG
  - MAPK9
  - KRAS
  - PRKCQ
  - MAPK3
  - PIK3R5
  - BRAF
  - HRAS
  - MAPK11
  - RAP1B
  - MAPK14
  - PTEN
  - MAPK8
  - RAF1
  - PRKCH
  - ARAF
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: N-Ras
  symbol: N-ras
  source: hgnc_alias_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: RET/PTC3
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: TSHR
  symbol: TSHR
  source: hgnc_symbol
  hgnc_symbol: TSHR
  entrez: '7253'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NTRK1)
  symbol: NTRK1
  source: hgnc_symbol
  hgnc_symbol: NTRK1
  entrez: '4914'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: A2/+
  symbol: A-2
  source: hgnc_alias_symbol
  hgnc_symbol: GPR162
  entrez: '27239'
- word: RET/PTC3
  symbol: PTC3
  source: hgnc_alias_symbol
  hgnc_symbol: NCOA4
  entrez: '8031'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Rap1b
  symbol: RAP1B
  source: hgnc_symbol
  hgnc_symbol: RAP1B
  entrez: '5908'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Pten-
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2861953__F2
redirect_from: /figures/PMC2861953__F2
figtype: Figure
---
